Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

EGRX Quote, Trading Chart, Eagle Pharmaceuticals Inc.


home / stock / egrx / egrx quote

$43.08 Last:

3.04% Change Percent:

$42.48 Open:

$43.08 Previous Close:

$44 High:

$41.41 Low:

170,920 Volume:

03/05/2021 03:15:23 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-0542.4843.084441.41170,920
2021-03-0440.4841.8142.4340.32203,255
2021-03-0340.5440.3242.1739.895133,795
2021-03-0243.9240.444.5440.4185,525
2021-03-0144.8545.3845.9444.4155,338
2021-02-2645.7544.546.4543.8021168,007
2021-02-2545.5645.7846.5745.46111,716
2021-02-2445.7845.6846.8945.260192,621
2021-02-2345.7645.4846.4944.61104,447
2021-02-2245.0545.945.995644.45142,696
2021-02-1946.2545.4746.645.16135,178
2021-02-1847.3646.2948.1446.0682,823
2021-02-1745.6747.7448.2445.5187,472
2021-02-1646.4346.1646.7944.455169,493
2021-02-1547.7746.3549.22546.1397,167
2021-02-1247.7746.3549.22546.1397,167
2021-02-1149.8748.0150.8747.80593,499
2021-02-1050.2549.9651.35549.7103,759
2021-02-0950.4249.951.062549.2788,121
2021-02-0849.6550.4550.849.196,180
Stock Information

Eagle Pharmaceuticals Inc. Company Name:

EGRX Stock Symbol:

NASDAQ Market:

Eagle Pharmaceuticals Inc. Website:

MENU
EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT EGRX NEWS
  • EGRX - Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q4 2020 Earnings Call Mar 2, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript ...

  • EGRX - Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review

    -- Q4 2020 net income was $0.62 per basic and $0.60 per diluted share and adjusted non-GAAP net income was $0.98 per basic and $0.96 per diluted share – -- FY 2020 net income was $0.89 per basic and $0.87 per diluted share and adjusted non-GAAP net income was $3.62 per ba...

  • EGRX - Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021

    Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 2, 2021, before the market opens. Scott Tarriff, Chief Executive ...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News